SCHEMBL251605

SCHEMBL251605

C=CCOC([O])C=C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL306260 1.00
SCHEMBL11404077 0.74
SCHEMBL1964304 0.72
SCHEMBL11618678 0.72
SCHEMBL2342556 0.72
SCHEMBL25324243 0.71 CA1 (0.32)
SCHEMBL2048729 0.71 CA1 (0.32)
SCHEMBL1062072 0.69 CA1 (0.35)
SCHEMBL1243413 0.69 CA1 (0.35)
SCHEMBL6897696 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1345920-B1 NOVEL SULFAMIDES AND THEIR USE AS ENDOTHELIN RECEPTOR ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2006-04-12 EP claimed
JP-3350048-B2 2002-11-25 JP claimed
US-5593981-A Method and treatment of androgen-related diseases ENDORECHERCHE INC. (CA) 1997-01-14 US claimed
US-5372996-A Method of treatment of androgen-related diseases ENDORECHERCHE, INC. (CA) 1994-12-13 US claimed
US-5364847-A Inhibitors of sex steroid biosynthesis and methods for their production and use ENDORECHERCHE (CA) 1994-11-15 US claimed
EP-0595796-A1 METHOD OF TREATMENT OF ANDROGEN-RELATED DISEASES ENDORECHERCHE INC. (CA) 1994-05-11 EP claimed
EP-0485392-A1 ANDROGEN DERIVATIVES FOR USE IN THE INHIBITION OF SEX STEROID ACTIVITY ENDORECHERCHE INC. (CA) 1992-05-20 EP claimed
WO-1991000733-A1 METHOD OF TREATMENT OF ANDROGEN-RELATED DISEASES ENDORECHERCHE INC. (CA) 1991-01-24 WO claimed
WO-1991000732-A1 ANDROGEN DERIVATIVES FOR USE IN THE INHIBITION OF SEX STEROID ACTIVITY ENDORECHERCHE INC. (CA) 1991-01-24 WO claimed
US-9586945-B2 Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy AbbVie Deutschland GmbH & Co. KG (DE) 2017-03-07 US disclosed
US-9365512-B2 Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy AbbVie Deutschland GmbH & Co. KG (DE) 2016-06-14 US disclosed
US-9238619-B2 Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy AbbVie Deutschland GmbH & Co. KG (DE) 2016-01-19 US disclosed
US-9067871-B2 Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy AbbVie Deutschland GmbH & Co. KG (DE) 2015-06-30 US disclosed
US-9051280-B2 Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy AbbVie Deutschland GmbH & Co. KG (DE) 2015-06-09 US disclosed
EP-0595796-A1 METHOD OF TREATMENT OF ANDROGEN-RELATED DISEASES ENDORECHERCHE INC. (CA) 1994-05-11 EP disclosed
EP-0485392-A1 ANDROGEN DERIVATIVES FOR USE IN THE INHIBITION OF SEX STEROID ACTIVITY ENDORECHERCHE INC. (CA) 1992-05-20 EP disclosed
EP-0462189-A1 COMBINATION THERAPY FOR TREATMENT OF ESTROGEN SENSITIVE DISEASES. ENDORECHERCHE INC (CA) 1991-12-27 EP disclosed
WO-1991000733-A1 METHOD OF TREATMENT OF ANDROGEN-RELATED DISEASES ENDORECHERCHE INC. (CA) 1991-01-24 WO disclosed
WO-1991000732-A1 ANDROGEN DERIVATIVES FOR USE IN THE INHIBITION OF SEX STEROID ACTIVITY ENDORECHERCHE INC. (CA) 1991-01-24 WO disclosed
WO-1990010462-A1 COMBINATION THERAPY FOR TREATMENT OF ESTROGEN SENSITIVE DISEASES ENDORECHERCHE INC. (CA) 1990-09-20 WO disclosed